1. Appropriate Stroke Prevention Strategies in Atrial Fibrillation

3. Atrial Fibrillation A Growing Epidemic

4. Atrial Fibrillation Risk of Stroke

5. Atrial Fibrillation Risk of Stroke (cont)

6. 2014 AHA/ACC/HRS Guidelines

7. 2016 ESC Guidelines

8. 2016 Canadian Guidelines

9. Inappropriate Dosing

10. Inappropriate Underdosing

11. XANTUS: Inappropriate Dose Reductions

12. Renal Clearance of NOACs

13. NOAC Dosing in Renal Dysfunction: US Labeling for Patients With AF

14. Patients With Impaired Renal Function

15. Patients With Impaired Renal Function (cont)

16. NOACs in Hemodialysis

17. NOACs in Elderly Patients

18. NOACs in Elderly Patients (cont)

19. EHRA Practical Guide on NOAC Anticoagulation for AF

20. Reversal Agents

21. Summary

22. Abbreviations

23. Abbreviations (cont)